semaglutide compounding news november 2025 Novo cuts GLP-1 prices 70%, but revenue could grow in 2026 The weight loss drug shortage

Best results after 3 months of consistent, daily use.

Health Canadas classification of peptides depends on intended use, marketing claims, and manufacturing standards

It is NOT a stimulant

Knowing what happens during each phase allows better planning and reduces anxiety during normal plateaus

This article will review the data behind these conjectures and outline potential clinical utility and the need for future studies to truly understand the role of GLP-1 receptors in the lung

Injectable GLP-1s may be more suitable for: Patients aiming for the maximum possible reduction in body weight, those with co-existing conditions like heart disease or chronic kidney disease (due to specific FDA approvals for Ozempic), or those who prefer a simple weekly medication schedule